Key words: heat shock protein/heat shock gene expression/protein synthesis/cycloheximide ABSTRACT. Whena clone of Chinese hamster ovary (CHO) cells transfected with a plasmid containing a luciferase reporter gene under the control of the humanheat shock protein (hsp) 70 gene promoter was treated with cycloheximide during heat exposure at 42 and 43°C for 15 to 100 minutes and then incubated at 37°C after removal of cycloheximide, reporter gene expression was suppressed by the protein synthesis inhibitor only at small heat shock doses (i.e., heat shock of less than 40 minutes at 42°C and 15 minutes at 43°C). A similar stress dose-dependent suppression of reporter gene expression by cycloheximide was also demonstrated by treatment with sodium arsenite at 37°C. However, dexamethasone-dependent reporter gene expression in a different CHO clone was not inhibited after the inducer treatment for different times in the presence of cycloheximide. In addition, synthesis of most cellular proteins (except for hsp) was not affected after heat shock treatment with cycloheximide. The results suggested that the cycloheximide inhibition of gene expression is specific to hsp gene expression induced by limited stress doses. Furthermore, a prior 42°C heat shock treatment for 30 minutes induced a decreased responsiveness (tolerance) to a second 42°C heat treatment for hsp gene expression, but tolerance did not develop in cells exposed to the first heat shock in the presence of cycloheximide. These results confirm previous findings that induction of hsp gene expression by stress is balanced by the severity of stress and rate of protein synthesis. They also support the proposed model of autoregulation of hsp gene expression by levels of free hsp70.
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Cells exposed to environmental and physiological stress respond by a rapid and transient increase in the synthesis of a family of so-called heat shock or stress proteins (hsp). Indeed most members of the hsp family are synthesized in the cell as abundant constitutive proteins even under normal physiological conditions. In recent years evidence has revealed that hsps have essential functions as molecular chaperons involved in protein folding, translocation, assembly to higher structures, and protein degradation (1-3). During heat shock or other forms of stress, these functions appear to prevent and repair damage caused by stress-induced protein denaturation and aggregation. In eukaryotes, stress-induced hsp gene expression is controlled by a transcriptional regulator referred to as the heat shock transcription factor (HSF) (4). HSF is present in an inactive monomericform under normal conditions and becomesactivated as a consequenceof exposure to stress by forming a trimer. Activated HSF trimer binds to a highly conserved upstream response element found in multiple copies in the promoter region of hsp genes. Questions arise regarding the molecular mechanisms for control of HSFactivity. What are the intracellular stress-induced signals that lead to activation of HSF, and how are the signals transmitted to change the inactive HSF monomeric form into an active trimeric form and vice versa? Biochemical evidence has suggested the following model for regulation of HSF activity. Under normal conditions, HSF is maintained in a non-DNAbinding form through interactions with hsp70 that stabilize the monomericstructure of HSF. During heat shock, misfolded or aggregated proteins are formed which compete with HSFfor association with hsp70. Thus, heat shock initiates the events that lead to removal of the negative regulatory influence on HSF. The released HSFassembles into trimer and binds to the promoter elements to activate hsp gene transcription (5-10). In the model, the association of HSF with hsp70 is important in regulating its transcriptional activity.
Another aspect of importance in cellular heat shock response is acquisition of a transient resistance (thermo-tolerance) to the killing effect of severe heat exposure after moderate heat shock treatment. Heat treatment in the presence of cycloheximide. A PMAM-HSluc cell clone that stably expressed luciferase gene depending on heat shock treatment was cultured in 35 mm dishes at 37°C for 2 or 3 days. After culture was replaced with fresh mediumthe cells were pretreated with cycloheximide for 10 minutes at 37°C and then heat-treated in the presence of cycloheximide by putting the dishes in CO2 incubators in which the temperature was set at 42 and 43°C. After treatment for Dexamethasone treatment in the presence of cycloheximide. A PMAM-luccell clone that stably expressed luciferase gene depending on dexamethasone induction was treated with or without cycloheximide in a fresh mediumat 37°C for 10 minutes, treated with dexamethasone (2 fiM) with or without cycloheximide at 37°C for 1, 2 and 3 hours. After the treatment, cells were washedfree of dexamethasoneand cycloheximide and then incubated at 37°C for another 3 hours to express the luciferase gene. Protein synthesis analysis by polyacrylamide gel electrophoresis. PMAM-HSluc cells were pretreated with cycloheximide (0.5 fiM) for 10 minutes at 37°C and then heat-treated at 42°C for 30 and 90 minutes with or without cycloheximide. Cells washed with methionine-free medium, were incubated in medium containing [35S]-methionine (1.85 MBq/ml) at 37°C for 2 hours to label cells. Labeled cells were treated with a lysis buffer (50mM Tris-HCl, pH 7.2, 150mM NaCl, 1% Triton X-100, \% sodium deoxycholate, 1% SDS, 1 mM EDTA) and the lysate was centrifuged at 15,000 rpm for lO min. Supernatant solutions were treated overnight with mouse monoclonal antibody against human hsp70 protein (Stress Gen Bio- cell line was heat-treated at 42°C for various times up to 60 minutes and then incubated at 37°C for 5 hours, the cells were induced for hsp70B promoter-directed luciferase gene expression depending on the heat treatment time (data not shown). Cells were treated with cycloheximide (0.25 pM) at 37°C for 10 minutes and then heattreated at 42°C for various times up to 100 minutes in the presence of cycloheximide. Control cells were heattreated without cycloheximide treatment. The cells were then washedto removecycldheximideand incubated at 37°C for 5 hours for luciferase gene expression. Induction of reporter gene expression was delayed and suppressed in the cells heat-treated in the presence of cycloheximide for the short times of 20 and 40 minutes (Fig.  1A) . Reporter gene expression, however, was rapidly induced by increasing the time of heat treatment in the presence of cycloheximide and was no longer suppressed after heat treatment for 80 and 100 minutes. Next hours after the cells were heat-treated at 42°C for 30 and 90 minutes without cycloheximide, reporter gene expressions induced by the two different heat doses were inhibited equally due to the translational inhibition by cycloheximide (data not shown).
A similar transient suppression of induction of reporter gene expression was also demonstrated by heat treatment at 43°C in the presence of cycloheximide (Fig. 2) . At this temperature, the delay of induction by cycloheximide treatment was shortened to approximately 10 minutes (Fig. 2) , compared to the delay of about 20 minutes in heat treatment at 42°C (Fig. 1A) . After the 10-minute delay, the reporter gene was expressed with a similar kinetic as that of control cells heated at 43°C without cycloheximide. The greater reporter gene expression after heating at 43°C for 45 and 60 minutes with cycloheximide mayreflect the protective effect of cycloheximide against heat-induced cellular damage. Suppression of reporter gene expression by cyclohexi- Concentration of NaAsCte (jiM) Fig. 3 . Effect of cycloheximide (CHX) on arsenite-induced hsp70B-luciferase gene expression. PMAM-HSluc cells were pretreated with (à") or without (O) CHX (0.5 (iM) at 37°C for 10 minutes, treated with the indicated concentrations of NaAsO2at 37°C for 3 hours with or without CHX,washed free of arsenite and CHX,and then incubated at 37°C for another 3 hours. Luciferase activities expressed in the total 6 hours of incubation were corrected for the activities expressed in the first 3 hours of incubation, and the luciferase activities expressed in the latter 3 hours of incubation were plotted. Inset: Percentage of luciferase activity in cells treated with various concentrations of NaAsO2 and with (black bar) or without (white bar) CHX. mide was also demonstrated in cells exposed to sodium arsenite. Cells were treated with various concentrations of sodium arsenite (5 to 60fiM) at 37°C for 3 hours with or without cycloheximide (0.5 j«M), washed free of arsenite and cycloheximide, and then incubated further for 3 hours at 37°C. Figure 3 shows that reporter gene expression in the latter 3-hour incubation is increased depending on the concentrations of arsenite added to the first 3 hour incubation. The expression was suppressed by cycloheximide treatment only in cells exposed to lower concentrations of arsenite (up to 10 fiM). Furthermore, suppression was also only demonstrated in cells treated for times of less than 1 hour with a high dose of arsenite (50 fiM) together with cycloheximide (0.5 ftM) (data not shown), but not in cells similarly treated for a longer time (3 hours; see Fig. 3 ). All these results revealed that cycloheximide suppressed hsp gene expression only when cells were exposed to a limited range of stress doses.
Cycloheximide suppression is specific to the stress gene promoter-directed expression. To examine the effect of cycloheximide on a different gene expression. PMAM-luc cells in which luciferase reporter gene expression was induced by dexamethasone treatment were treated with dexamethasone (2 fiM) in the presence or absence of cycloheximide (0.5 fiM) at 37°C for different times of 1, 2 and 3 hours. The cells were washedfree of dexamethasone and cycloheximide, and incubated for 3 hours at 37°C to express reporter gene. Control reporter gene expression in the latter 3-hour incubation increased with the times of dexamethasone induction (Fig. 4) . The gene expression was not significantly inhibited by cycloheximide treatment during the different dexamethasone-induction times. The data indicated that the dexamethasone-responsive promoter activation was not affected by cycloheximide treatment.
Wealso examined the effect of cycloheximide on cellular protein synthesis after heat shock exposure in the presence or absence of cycloheximide. The PMAMHSluc cells were heat-treated at 42°C for 30 and 90 minutes with cycloheximide (0.5 fiM). After removal of cycloheximide cells were incubated with [35S]-methionine at 37°C for 2 hours to label proteins synthesized after the heat shock. Cell lysates were prepared and treated with a monoclonal antibody against human hsp70. The immunoprecipitates were analyzed for hsp70 synthesis, and cell lysates for most other cellular protein synthesis.
The gel analysis of immunoprecipitates revealed that the radioactive band of hsp70 was significantly decreased as expected after heat treatment at 42°C for 30 minutes in the presence of cycloheximide ( of thermotolerance. We examined hsp70B-luciferase gene expression for responsiveness to second heat treatment (after first heat treatment). Cells were heat-treated at 42°C for 30 minutes and then incubated at 37°C for 3 hours to express the reporter gene. The cells werethen exposed to a second heat shock at 42°C for 30 minutes and subsequently incubated at 37°C for 3 hours to express the reporter gene in response to the second heat treatment. The results are summarizedin Table I . Cells expressed the reporter gene in response to the first 42°C heat treatment (exp. 1 to 3). The reporter luciferase activity expressed after the first heat shock was decreased by the second heat treatment (exp. 2 vs. 4), probably due to inactivation of enzyme activity by heating of cells, since luciferase activity was found to be reduced 
DISCUSSION
We demonstrated in the present study that the human hps70B promoter-luciferase gene expression in a CHO cell line in response to stress treatment with elevated temperatures at 42 and 43°C and sodium arsenite was suppressed whencells were exposed to the protein synthesis inhibitor cycloheximide during exposure to various doses of stress. The kinetic analyses revealed that the suppression wasdependenton the severity of stress; it was reduced by increasing the time and amount of heat and arsenite treatments, and no longer occurred in severe stress treatments. This stress dose-dependent transient suppression induced by the protein synthesis inhibitor cycloheximide was specific to hsp gene expression; neither cellular protein synthesis (except for hsp synthesis) (Fig. 5 ) nor dexamethasone-dependent reporter gene expression (Fig. 4) was affected by the inhibitor.
In our study cycloheximide was added to cells at 37°C only 10 minutes before cells were exposed to heat shock and arsenite treatment. Furthermore, the quantitative data of reporter gene expression allowed the kinetic analyses of the stress dose-dependent effect of cycloheximide. Wealso obtained quantitative data of cycloheximide dose effects in the two different heat treatment conditions (Fig. IB) , tolerance development (Table I) HSFactivity is subjected to positive (negative) regulation by levels of denatured proteins (rate of protein synthesis). Thus the negative effect induced by cycloheximide inhibition of protein synthesis may balance the positive effect caused by a range of modest stress exposure, but may be overcome by the effect of severe stress. This model of autoregulation of hsp gene expression of levels of free hsp70 has also been proposed by others (7, 8).
A family of heat shock proteins is suggested to play a role in the development of thermotolerance (1 1-13). We demonstrated that an unresponsiveness (tolerance) for hsp gene expression to the second heat treatment at 42°C was developed after exposure to the first 42°C for 30 minutes (Table I ). This tolerance development was inhibited by cycloheximide treatment during the first heat exposure. Our preliminary data also showed that the cells exposed to the first heat shock at 42°C for 30 minutes together with cycloheximide did not develop resistance during subsequent incubation at 37°C to the next cell killing at 43°C heat challenge (unpublished data). These data support that a hsp70 family of proteins synthesized after the first heat shock induction plays a role in the development of thermotolerance. Abnormal expression of stress proteins has been widely observed in a number of diseases, including oxidant injury, ischemia, cardiac hypertrophy, fever, inflammation, metabolic diseases, tissue trauma, neuronal injury and cancer, as well as in aging (14) (15) (16) . Therefore development of biologically interesting molecules that specifically modulate the stress response maybe important not only for basic biology but also for its application in treating diseases. Several chemical compoundsof HSF activator identified include salicylates, prostaglandins and arachidonic acid, all of which are involved in the inflammatory response (17) (18) (19) (20) . A flavonoid compound, quercetin, has been shown to inhibit the synthesis of heat shock proteins at the level of transcription (21, 22). Quercetin was extensively studied to determine its molecular mechanismof action. It inhibits the binding of HSFto the heat shock element by not affecting the trimer formation of HSFbut perhaps by decreasing the level of phosphorylated form of HSF (23, 24) . To develop novel such stress response modulators, we have searched for active substances in microbial-derived products by using the hsp promoter-reporter system described in the present study. Werecently identified an activity which preferentially inhibits the heat-induced reporter gene expression rather than the dexamethasonedependent reporter gene expression. Weare currently purifying the active substance, and the work will be shortly reported elsewhere.
